Clinical Trial Update: Cardiovascular Events in GnRH Agonist vs. Antagonist [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing GnRH agonist vs antagonist with a focus on cardiovascular events in prostate cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Rabin Medical Center | Conditions: Hormone Sensitive Prostate Cancer, Prostate Cancer | Phase 2 | Status: UNKNOWN